image
Healthcare - Biotechnology - NASDAQ - US
$ 0.4035
-1.59 %
$ 68 M
Market Cap
3.1
P/E
BALANCE SHEET
147 M ASSETS
-5.35%
96.2 M LIABILITIES
17.94%
51.1 M EQUITY
-30.99%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition X4 Pharmaceuticals, Inc.
image
Current Assets 122 M
Cash & Short-Term Investments 114 M
Receivables 562 K
Other Current Assets 7.3 M
Non-Current Assets 25.2 M
Long-Term Investments 0
PP&E 6.4 M
Other Non-Current Assets 18.8 M
Current Liabilities 22.9 M
Accounts Payable 8.95 M
Short-Term Debt 2.2 M
Other Current Liabilities 11.7 M
Non-Current Liabilities 73.3 M
Long-Term Debt 57.2 M
Other Non-Current Liabilities 16.1 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 99.2 121.7 81.8 78.7 126.2 30.8 76.8 3.0 6.8
Short Term Investments 15.0 0 0 0 0 0 0 0 0
Receivables 0.6 1.2 0.7 0.9 2.0 2.9 1.6 1.3 1.5
Inventory 0 0 0 0 0 0 0.4 1.2 0
Other Current Assets 7.3 5.8 5.3 3.7 1.1 1.5 1.1 1.3 87 K
Total Current Assets 122.1 128.7 87.9 83.3 129.3 35.1 80.8 5.7 8.4
PP&E 6.4 8.3 10.2 9.2 2.4 0.3 0.4 0.5 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 17.4 17.4 17.4 27.1 27.1 0 0 0 0
Long Term Investments 0 1.0 1.3 1.7 1.9 0.4 0.4 0.4 0.3
Other Long Term Assets 1.4 1.2 1.7 3.3 1.9 0.3 (0.4) 1.0 25 K
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 147.3 155.6 117.2 122.9 160.7 36.0 81.3 7.6 9.5
LIABILITIES
Accounts Payable 8.9 7.8 4.3 3.1 2.1 0.5 1.9 1.6 0.4
Short Term Debt 2.2 3.7 2.9 1.6 1.8 1.7 2.3 3.5 2.1
Other Current Liabilities 11.7 10.8 6.8 7.2 5.6 2.4 5.8 4.8 3.3
Total Current Liabilities 22.9 22.3 14.0 11.9 9.4 5.4 7.7 12.1 6.7
Long Term Debt 57.2 35.9 37.9 37.7 22.0 7.9 9.9 (29.7) (25.2)
Deferred Tax Income 0 0 0 0 0 0 9 K 39.8 29.9
Other Liabilities 16.1 23.3 0.8 0.5 16 K 5 K 9 K (39.8) (29.9)
Total Liabilities 96.2 81.5 52.8 50.1 31.5 14.4 22.5 64.2 43.8
EQUITY
Common Stock 0.2 0.1 28 K 16 K 16 K 15 K 15 K 1 K 1 K
Retained Earnings (477.9) (376.7) (282.9) (194.2) (132.0) (135.3) (92.3) (58.4) (35.4)
Other Accumulative Comprehensive Income/Loss (0.1) (0.1) (0.1) (0.1) (0.1) 0.2 0.1 0.8 0.7
Total Equity 51.1 74.1 64.4 72.8 129.2 21.6 58.7 (56.6) (34.3)
Total Liabilities and Equity 147.3 155.6 117.2 122.9 160.7 36.0 81.3 7.6 9.5
SHARES OUTSTANDING
Common Shares Outstanding 177.8 63.5 25.7 20.1 11.5 0.5 0.3 0.9 0.9